Home / Stocks / TMCI

TMCI insider trading

TREACE MEDICAL CONCEPTS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
8
Bought · 24 mo
$2.2M
Buys · last 90 days
3 · $557k
Most recent buy
2026-08-24

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-24Treace John T.
Chief Executive Officer
Bought55,944$4.41$247k
2026-06-12Treace John T.
Chief Executive Officer
Bought24,606$4.03$99k
2026-06-11Treace John T.
Chief Executive Officer
Bought52,317$4.03$211k
2026-06-01Treace John T.
Chief Executive Officer
Bought50,000$3.56$178k
2026-05-28Treace John T.
Chief Executive Officer
Bought115,520$2.95$340k
2026-05-14Treace John T.
Chief Executive Officer
Bought153,763$2.44$376k
2025-03-04Treace John T.
Chief Executive Officer
Bought60,000$8.73$524k
2024-09-17Treace John T.
Chief Executive Officer
Bought50,000$5.31$266k

Most active insider buyers

InsiderRoleBuysTotal bought
Treace John T.Chief Executive Officer8$2.2M

See TMCI on the chart

Every insider buy and sell for TMCI plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.